Oncopeptides AB
F:OND
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Oncopeptides AB (OND) under the Base Case is 0.188 EUR per share.
Compared with the current market price of 0.164 EUR, the stock appears
Undervalued by 13% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Oncopeptides AB Does
Oncopeptides AB is a Swedish biotechnology company focused on treatments for blood cancers, especially multiple myeloma. Its main work is developing drugs that attack cancer cells in a different way from standard chemotherapy, with the goal of helping patients whose disease has come back or stopped responding to earlier treatment.
- Headquarters
- Sweden SE
- Employees
- 75
- IPO date
- Feb 22, 2017
Revenue & Expenses Breakdown
Oncopeptides AB
Earnings Waterfall
Oncopeptides AB
What is the Intrinsic Value of one OND stock?
The intrinsic value for Oncopeptides AB (OND) under the Base Case is 0.188 EUR.
Is OND stock undervalued or overvalued?
Compared with the current market price of 0.164 EUR, the stock appears Undervalued by 13% .
